BrainsWay Announces First Coverage Policy for Accelerated Deep TMS™

BrainsWay’s SWIFT depression protocol consists of an acute phase of five treatment sessions (ten minutes each) per day for ...
Psychology Today

Neuromodulation in Addiction Treatment

When most people consider treatment for psychiatric problems, they usually consider medications and/or psychotherapy. However, emerging neuromodulation approaches using transcranial magnetic ...
Seeking Alpha

Clinical TMS Society Publishes First Coverage Recommendations for the Treatment of Smoking Addiction

BURLINGTON, Mass. and JERUSALEM, Nov. 02, 2023 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (BWAY) (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...
Healio

Coordinated transcranial magnetic stimulation, ketamine may benefit refractory depression

Please provide your email address to receive an email when new articles are posted on . Ketamine provides rapid action, and transcranial magnetic stimulation offers durability. Both treatments involve ...

BrainsWay Wins Optum Coverage Expansion for Adolescent Deep TMS Depression Therapy

Detailed price information for Brainsway Ltd ADR (BWAY-Q) from The Globe and Mail including charting and trades.
Nasdaq

BrainsWay Receives FDA Clearance for Accelerated Deep TMS Protocol for Non-Invasive Treatment of Major Depressive Disorder (MDD)

BURLINGTON, Mass. and JERUSALEM, Sept. 16, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation ...